Dr. Peter Vu, MD

Dr. Vu practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Vu's NPI, 1861810830, was assigned on April 6, 2014. Dr. Vu graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014. Dr. Vu holds California license A149741.

Dr. Vu's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Vu's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Vu is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vu practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Vu's licenses on file in 4 states: California, District of Columbia, Illinois and Virginia.

Dmand AI lists colorectal cancer among the conditions Dr. Vu treats.

CMS data shows 908 Medicare services from Dr. Vu across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $62,641 for them.

CMS counts 127 Medicare patients who saw Dr. Vu in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vu's median patient age at 66, with 48% women.

In 2024, Dr. Vu wrote 415 Medicare Part D claims for 89 patients. 88% of them were for generic drugs. CMS names the drug for 263 of them, across 13 drugs with 11 or more claims each, at $50,923 in total drug cost. In 2023, CMS named 277 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Vu for performance year 2024, reported as part of a group. Dr. Vu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vu as offering telehealth.

Dmand AI links 7 papers to Dr. Vu, published from 2012 to 2024. 2019 was the busiest year, with 2. Dr. Vu has published most often in JCO Precis Oncol. Dr. Vu's most frequent co-authors are Sandip Pravin Patel, MD, Aaron Michael Goodman, MD and Lyudmila A. Bazhenova, MD.

CMS Open Payments shows 13 general payments to Dr. Vu from 9 drug and device companies from 2017 to 2025. Grants make up the largest share, 99% of the total. Pfizer Inc. paid the most, $98,013.

Dr. Vu graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014. Dr. Vu is a member of ASCO.

Dr. Vu is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.